144 related articles for article (PubMed ID: 8985045)
1. Radiation therapy in early carcinoma of the glottic larynx T1N0M0.
Medini E; Medini A; Gapany M; Levitt SH
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1211-3. PubMed ID: 8985045
[TBL] [Abstract][Full Text] [Related]
2. The role of radiotherapy in the management of carcinoma in situ of the glottic larynx.
Medini E; Medini I; Lee CK; Gapany M; Levitt SH
Am J Clin Oncol; 1998 Jun; 21(3):298-301. PubMed ID: 9626803
[TBL] [Abstract][Full Text] [Related]
3. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
Ricciardelli EJ; Weymuller EA; Koh WJ; Austin-Seymour M; DeSautel MG; Laramore GE
Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):737-42. PubMed ID: 8018326
[TBL] [Abstract][Full Text] [Related]
4. Curative radiotherapy for stage II-III squamous cell carcinoma of the glottic larynx.
Medini E; Medini I; Lee CK; Gapany M; Levitt SH
Am J Clin Oncol; 1998 Jun; 21(3):302-5. PubMed ID: 9626804
[TBL] [Abstract][Full Text] [Related]
5. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis.
Rudoltz MS; Benammar A; Mohiuddin M
Int J Radiat Oncol Biol Phys; 1993 Aug; 26(5):767-72. PubMed ID: 8344844
[TBL] [Abstract][Full Text] [Related]
7. The impact of treatment time and smoking on local control and complications in T1 glottic cancer.
van der Voet JC; Keus RB; Hart AA; Hilgers FJ; Bartelink H
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):247-55. PubMed ID: 9788401
[TBL] [Abstract][Full Text] [Related]
8. Long-term observations and salvage operations on patients with T2N0M0 squamous cell carcinoma of the glottic larynx treated with radiation therapy alone.
Furusaka T; Matuda H; Saito T; Katsura Y; Ikeda M
Acta Otolaryngol; 2012 May; 132(5):546-51. PubMed ID: 22264025
[TBL] [Abstract][Full Text] [Related]
9. Radiation therapy in early glottic carcinoma: uni- and multivariate analysis of prognostic factors affecting local control.
Sakata K; Aoki Y; Karasawa K; Hasezawa K; Muta N; Nakagawa K; Terahara A; Onogi Y; Sasaki Y; Akanuma A
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1059-64. PubMed ID: 7961012
[TBL] [Abstract][Full Text] [Related]
10. Hypofractionated radiotherapy for T1N0M0 glottic cancer: retrospective analysis of two different cohorts of dose-fractionation schedules from a single institution.
Laskar SG; Baijal G; Murthy V; Chilukuri S; Budrukkar A; Gupta T; Agarwal JP
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e180-6. PubMed ID: 22862908
[TBL] [Abstract][Full Text] [Related]
11. Early-stage glottic cancer: importance of dose fractionation in radiation therapy.
Kim RY; Marks ME; Salter MM
Radiology; 1992 Jan; 182(1):273-5. PubMed ID: 1727295
[TBL] [Abstract][Full Text] [Related]
12. Radiation therapy for T1,2 glottic carcinoma: impact of overall treatment time on local control.
Nishimura Y; Nagata Y; Okajima K; Mitsumori M; Hiraoka M; Masunaga S; Ono K; Shoji K; Kojima H
Radiother Oncol; 1996 Sep; 40(3):225-32. PubMed ID: 8940749
[TBL] [Abstract][Full Text] [Related]
13. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
[TBL] [Abstract][Full Text] [Related]
14. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?
Garden AS; Forster K; Wong PF; Morrison WH; Schechter NR; Ang KK
Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):322-8. PubMed ID: 12527044
[TBL] [Abstract][Full Text] [Related]
15. Clinical radiobiology of glottic T1 squamous cell carcinoma.
Skladowski K; Tarnawski R; Maciejewski B; Wygoda A; Slosarek K
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):101-6. PubMed ID: 9989520
[TBL] [Abstract][Full Text] [Related]
16. [Radiation therapy of early glottic cancer (T1N0M0); retrospective review of historical control].
Teshima T; Chatani M; Hata K; Inoue T
Rinsho Hoshasen; 1989 Dec; 34(13):1603-6. PubMed ID: 2622053
[TBL] [Abstract][Full Text] [Related]
17. Phase 1 Fractional Dose-Escalation Study of Equipotent Stereotactic Radiation Therapy Regimens for Early-Stage Glottic Larynx Cancer.
Sher DJ; Timmerman RD; Nedzi L; Ding C; Pham NL; Zhao B; Sumer BD
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):110-118. PubMed ID: 30880269
[TBL] [Abstract][Full Text] [Related]
18. Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital Experience.
Gowda RV; Henk JM; Mais KL; Sykes AJ; Swindell R; Slevin NJ
Radiother Oncol; 2003 Aug; 68(2):105-11. PubMed ID: 12972304
[TBL] [Abstract][Full Text] [Related]
19. Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions.
Ermiş E; Teo M; Dyker KE; Fosker C; Sen M; Prestwich RJ
Radiat Oncol; 2015 Sep; 10():203. PubMed ID: 26395876
[TBL] [Abstract][Full Text] [Related]
20. Radiation therapy for early glottic cancer (T1N0M0): I. Results of conventional open field technique.
Teshima T; Chatani M; Inoue T
Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1199-202. PubMed ID: 2513291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
